References
- Heaney ML, Golde DW. Myelodysplasia. N Engl J Med 1999;340:1649–1660.
- Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States. Cancer 2007;109:1536–1542.
- Cazzola M, Malcovati L. Myelodysplastic syndromes–coping with ineffective hematopoiesis. N Engl J Med 2005;352:536–538.
- Brunning RD, Hasserjian RP, Porwit A, et al Refractory cytopenia with unilineage dysplasia. In: Swerdlow SH, Campo E, Harris NL, et al, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008. pp. 94–95.
- Vardiman JW, Thiele J, Arber DA, et al The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937–951.
- Greenberg P, Cox C, LeBeau MM, et al International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079–2088.
- Greenberg P. [Erratum for Greenberg et al., Blood 1998;89:2079–2088]. Blood 1998;91:1100.
- Menke DM, Colon-Otero G, Cockerill KJ, Jenkins RB, Noel P, Pierre RV. Refractory thrombocytopenia. A myelodysplastic syndrome that may mimic immune thrombocytopenic purpura. Am J Clin Pathol 1992;98:502–510.
- Sashida G, Takaku TI, Shoji N, et al Clinico-hematologic features of myelodysplastic syndrome presenting as isolated thrombocytopenia: an entity with a relatively favorable prognosis. Leuk Lymphoma 2003;44:653–658.
- Fenaux P, Estienne MH, Lepelley P, et al Refractory anaemia according to the FAB classification: a report on 69 cases. Eur J Haematol 1988;40:318–325.
- Breccia M, Latagliata R, Cannella L, et al Refractory cytopenia with unilineage dysplasia: analysis of prognostic factors and survival in 126 patients. Leuk Lymphoma 2010;51:783–788.
- Hasserjian RP, Gupta P, Donohue K, Larson RA, Racke F, Bloomfield CD. Application of 2008 WHO classification criteria for myelodysplastic syndromes (MDS) without excess blasts: observations from Cancer and Leukemia Group B Study 10105. Mod Pathol 2009;22(Suppl. 1): Abstract 266.
- Verburgh E, Achten R, Louw VJ, et al A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification. Leukemia 2007;21:668–677.
- Pomeroy C, Oken MM, Rydell RE, Filice GA. Infection in the myelodysplastic syndromes. Am J Med 1991;90:338–344.
- Gurion R, Vidal L, Gafter-Gvili A, et al 5-Azacitidine prolongs overall survival in patients with myelodysplastic syndrome–a systematic review and meta-analysis. Haematologica 2010;95:303–310.